In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Clinical Trial Updates (CTUs)

ESC Congress 2014, Barcelona - press conference

Date & Time:  Monday 01 September, 13:00-14:00

Chairpersons
Prof. Michel Bertrand (France)
Prof. François Schiele (France)
Spokespersons
Prof. Eric Van Belle (France)
Prof. Carlo Di Mario (UK)

 



Prevention of Worsening Heart Failure by Serelaxin in Patients Admitted for Acute Heart Failure: Results from RELAX-AHF

Prof. John R. Teerlink, Va Medical Centre (San Francisco, USA)
Refers to session: Prevention of Worsening Heart Failure by Serelaxin in Patients Admitted for Acute Heart Failure: Results from RELAX-AHF
Press release  |  Slides

 

 

SYMPLICITY HTN-3: 12-month outcomes following unblinding of subjects at 6 months

Prof. George Bakris, Duchossois Center of Advanced Med (Chicago, USA)
Refers to session: SYMPLICITY HTN-3: 12-month outcomes following unblinding of subjects at 6 months
Press release  |  Slides

 

 

TASTE: One year outcome of The Thrombus Aspiration in ST-Elevation myocardial infarction in Scandinavia trial

Dr Bo Lagerqvist, Akademiska University Hospital (Sweden)
Refers to session: TASTE: One year outcome of The Thrombus Aspiration in ST-Elevation myocardial infarction in Scandinavia trial
Press release  |  Slides

 

 

FOCUS: Fixed-dose combination drug for secondary cardiovascular prevention

Dr Valentin Fuster, Mount Sinai Hospital (New York, USA)
Refers to session: FOCUS: Fixed-dose combination drug for secondary cardiovascular prevention
Press release  |  Slides

 

 

Fractional Flow Reserve-Guided PCI versus Medical Treatment in Stable Coronary Disease: FAME 2 Primary End-Point Data Analysis

Dr Bernard De Bruyne, Onze-Lieve-Vrouw Kliniek (Belgium)
Refers to session: Fractional Flow Reserve-Guided PCI versus Medical Treatment in Stable Coronary Disease: FAME 2 Primary End-Point Data Analysis
Press release  |  Slides

 




Abstracts linked to ESC press conferences are not available until embargo lifts. The embargo lifts at the beginning of the press conference or the scientific session, whichever comes first. All other abstracts will be online on 22 August, 2014 in the Scientific Programme Planner except for Hot Lines, Clinical Trial Update and Registries Hot Lines abstracts.
Press releases are available on site in the press kit (USB key) that you will receive once you pick up your badge at the press registration desk at ESC Congress 2014 - except for press releases on Clinical Trial Updates and Hot Line sessions which are only available when the embargo lifts.
Press slides will be available at the beginning of the press conference.
All ESC Press conferences will be broadcasted live. Unfortunately, no webcast will be available. Access to the session will be restricted to registered press only.
During the ESC Congress 2014, all scientific resources are available on ESC Congress 365.